Back to Panels

Panel Detail

Breakfast Roundtable Discussions

Tuesday, November 15, 2016
7:30 AM - 8:30 AM
GH-Ballroom II-IV

Kick off Monday and Tuesday of Partnering for Cures with an opportunity to network with peers who share your goals and interests. These roundtables bring together meeting participants from various disciplines and sectors. Roundtable hosts will establish common ground on the topics below, helping these informal gatherings to quickly turn into dynamic and productive conversations.

TUESDAY TABLE TOPICSTABLE HOST
Battling Autoimmune Disease: Recognizing Me for Me
Dan Peer, Director, The Leona M. and Harry B. Helmsley Nanotechnology Research Fund; Director, Focal Technology Area Consortium on Nanomedicine for Personalized Theranostics; Professor, Faculty of Life Science, Department of Cell Research & Immunology, Tel Aviv University
Building a Healthy Pipeline of Young Investigators
Christopher L. PickettDirector, Rescuing Biomedical Research
Collaboration: More than the Sum of the Parts

Catherine Kopil, Director, Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research

Joseph MenetskiDeputy Director, Research Partnerships, Foundation for the National Institutes of Health

Scott Plevy, Disease Area Stronghold Leader, Inflammatory Bowel Disease, Janssen Research and Development

De-risking Biomedical Product Development
Jim Schaeffer, Vice President, External Relations, Calibr
Diseases of Aging: Facing our Future
Samantha Hunter, Director of Development, Alliance for Aging Research
Evolving Landscape of Infectious Disease and Antibiotic Resistance

Pooja KothariAssociate, Antibiotic Resistance Project, Pew Charitable Trusts

David PardoeHead of Growth Projects, MRC Technology

Next Generation Clinical Trials and Master Protocols

Meredith BuxtonExecutive Director, I-SPY TRIALS Consortium; Assistant Professor, University of California, San Francisco

Jamie Roberts, Senior Clinical Project Manager, Clinical Trials Transformation Initiative 

Patient Engagement 2.0: Creating the Culture

Nikki Levy, Vice President, Patient Engagement, Alkermes

Christeen Moburg, Director, Stakeholder Engagement, Astellas

Katherine Maynard, Principal, PWR 

Precision Medicine: Putting the "Me" in Medicine

Stephanie Devaney, Science Policy & Outreach, Office of the Director, National Institutes of Health

Varda ShalevDirector, Institute for Health Research and Innovation, Maccabi Healthcare Services; CEO, Maccabitech

Presidential Transition and Policy Opportunities in 2017

Robert Cook-Deegan, Senior Fellow, FasterCures; Professor, School for the Future of Innovation in Society, Arizona State University

Pat White, President, ACT for NIH: Advancing Cures Today

Putting Tech to Work for Health
Elizabeth Richardson, Managing Associate, Duke-Margolis Center for Health Policy
Road-mapping Rare Diseases: Signs of Success

Emily Kramer-Golinkoff, Founder, Emily's Entourage 

Michael Goettler, Global President, Rare Disease Global Innovative Pharma Business, Pfizer

Trends in Nonprofit Financing: Getting Innovative

Terri CooperFederal Health Care Sector Leader, Deloitte Consulting

Kimberly Myers, Senior Manager, Deloitte Consulting


Topics are subject to changes, additions and deletions prior to Partnering for Cures.